“Innovative Hybrid Compounds Targeting Tuberculosis: Development, Characterization and Bioefficacy Analysis of 6-Substituted-2-Chloroquinoline-3-Carbaldehyde Hydrazide Ester Derivatives”. 2024. International Journal of Pharmaceutical Sciences and Drug Research 16 (3): 378-86. https://doi.org/10.25004/IJPSDR.2024.160309.